| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Article abstract-We studied the effects of botulinum toxin A in 12 patients with spasticity and in eight patients with rigidity. The study design was a double-blind, placebo-controlled crossover trial with botulinum toxin A versus saline. Using the Ashworth Scale for spasticity and the Unified Parkinson's Disease Rating Scale for rigidity, we gave the patients a tone grade before and 2 weeks after treatment. Improvement in tone by two grades or more was considered clinically significant. In the spasticity group, botulinum toxin A reduced the tone of all patients significantly, improved functionality and nursing care in eight of 12 patients, and alleviated painful spasms in five of five patients. In the rigidity group, muscle tone was decreased in seven of eight patients, functionality improved in four of seven, and joint and muscle pain decreased in four of five. We conclude that botulinum toxin A is effective against the disabling effects of spasticity and rigidity. The treatment was well tolerated.
NEUROLOGY 1995;45: 712-717
This article has been cited by other articles:
|
|
 |
|
  M. Giovannelli, G. Borriello, P. Castri, L. Prosperini, and C. Pozzilli Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis Clinical Rehabilitation, April 1, 2007; 21(4): 331 - 337. [Abstract] [PDF]
|
|
|
|
 |
|
 J Jankovic Botulinum toxin in clinical practice J. Neurol. Neurosurg. Psychiatry, July 1, 2004; 75(7): 951 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Delgado Botulinum Neurotoxin Type A J. Am. Acad. Ortho. Surg., September 1, 2003; 11(5): 291 - 294. [Full Text] [PDF]
|
|
|
|
|
|
J SASTRE-GARRIGA, M TINTORE, X MONTALBAN, J BAGO, and I FERRER Response to botulinum toxin in a case of rigid spine syndrome J. Neurol. Neurosurg. Psychiatry, October 1, 2001; 71(4): 564 - 565. [Full Text]
|
|
|
|
 |
|
 L. Foster, L. Clapp, M. Erickson, and B. Jabbari Botulinum toxin A and chronic low back pain: A randomized, double-blind study Neurology, May 22, 2001; 56(10): 1290 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Heckmann, A. O. Ceballos-Baumann, G. Plewig, and The Hyperhidrosis Study Group Botulinum Toxin A for Axillary Hyperhidrosis (Excessive Sweating) N. Engl. J. Med., February 15, 2001; 344(7): 488 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C DAVIS and M. P BARNES Botulinum toxin and spasticity J. Neurol. Neurosurg. Psychiatry, August 1, 2000; 69(2): 143 - 147. [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Kwak, P. A. Hanna, and J. Jankovic Botulinum Toxin in the Treatment of Tics Arch Neurol, August 1, 2000; 57(8): 1190 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Gelber and P. B. Jozefczyk Therapeutics in the Management of Spasticity Neurorehabil Neural Repair, March 1, 1999; 13(1): 5 - 14. [Abstract] [PDF]
|
|
|
|
|
|
C. Sampaio, J. J Ferreira, A. A Pinto, M. Crespo, J. M Ferro, and A. Castro-Caldas Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patients Clinical Rehabilitation, February 1, 1997; 11(1): 3 - 7. [Abstract] [PDF]
|
|
|
|
|
|
S. L. Pullman, P. Greene, S. Fahn, and S. F. Pedersen Approach to the Treatment of Limb Disorders With Botulinum Toxin A: Experience With 187 Patients Arch Neurol, July 1, 1996; 53(7): 617 - 624. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Hesse, J. Krajnik, D. Luecke, M.T. Jahnke, M. Gregoric, and K.H. Mauritz Ankle Muscle Activity Before and After Botulinum Toxin Therapy for Lower Limb Extensor Spasticity in Chronic Hemiparetic Patients Stroke, March 1, 1996; 27(3): 455 - 460. [Abstract] [Full Text]
|
|
|
|
|
|
F. Reiter, M. Danni, M. G. Ceravolo, and L. Provinciali Disability Changes After Treatment of Upper Limb Spasticity with Botulinum Toxin Neurorehabil Neural Repair, January 1, 1996; 10(1): 47 - 52. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
